Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls - Wikidata - wikimedia - TriplyDB

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

http://www.wikidata.org/entity/Q37259426

about

Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.Untangling tau imaging Revolutionizing Alzheimer's disease and clinical trials through biomarkers The amyloid hypothesis of Alzheimer's disease at 25 years Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT New Features about Tau Function and Dysfunction Chronic Traumatic Encephalopathy: The Impact on Athletes Insight into the Molecular Imaging of Alzheimer's Disease Characteristics of Tau and Its Ligands in PET Imaging Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging Suspected non-Alzheimer disease pathophysiology--concept and controversy Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 Imaging pathological tau in atypical parkinsonian disorders Early failure of the default-mode network and the pathogenesis of Alzheimer's disease Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis Therapeutic and diagnostic challenges for frontotemporal dementia Diagnosis and management of behavioral variant frontotemporal dementia Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging Expanding the phenotypic associations of globular glial tau subtypes.Neuroimaging in vascular cognitive impairment: a state-of-the-art review Spreading of pathology in neurodegenerative diseases: a focus on human studies High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection The neuropathology of sport Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model Validation of the new consensus criteria for the diagnosis of corticobasal degeneration Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors Neurostatistical imaging for diagnosing dementia: translational approach from laboratory neuroscience to clinical routine.Neuroimaging in Parkinson disease: from research setting to clinical practice.Recent imaging advances in neurology.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.The role of biomarkers and imaging in Parkinson's disease.Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.Future Directions in Imaging Neurodegeneration.Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.After disappointments, Alzheimer's researchers seek out new paths: biomarkers and combination therapies may lead to disease-modifying treatments, experts say.

P2860

Q21146623-238B8055-A4FB-4DF4-9053-2D2B561E8D8B Q24040265-F30443AD-AE33-44E9-84BA-0BBB34C75881 Q26739091-512CCD29-D8B6-4C97-9E84-414202884920 Q26744882-EF09CC6E-E2B1-444D-BB82-F7703FA2FE74 Q26749528-303084D3-7F24-49A1-BA1C-60D91FC69E1A Q26749755-58CCBA52-30D8-4FC5-A857-411B6C927A05 Q26750922-36EF1EA0-F8DD-4515-B7A0-CF8D4FBBDA9C Q26752835-933B6277-9865-4F11-8566-94633BAB7EE1 Q26765945-8995C9C6-92FA-4190-9B5A-EFF263D0235E Q26769952-42DF92C6-C7C3-4E91-A3A1-F76D38E873D8 Q26770766-9A37FD4D-E809-4D5A-88B7-D870FEEA2668 Q26771270-748ECD9F-9BFC-4B1B-ACFF-5C1C34EA1A73 Q26781672-53EB9DD0-F8A8-4AB2-A78C-9A98ECA6F64E Q26801629-C7682C1B-3622-4FB4-97EB-0A226DCB7718 Q26801654-91601E22-7E9D-4E9D-ACD3-3CA16D614B2D Q26823039-577DA561-A089-4BF4-8110-350445E3934A Q26862463-BD56B217-6390-4AF4-9369-48F53A5570C1 Q26995432-8EAD3F0E-77DF-4A90-A997-17C0F9854F96 Q26998919-6E32BD66-6372-44BD-A726-A84170404E39 Q27006258-C5702EC4-AB68-4CF2-8B2A-95B156533428 Q27020981-47D05DB7-E02B-48FC-AB70-55FE9BF2F41C Q27315448-24D66462-8BCD-4C1F-9FB2-F0C6A4854222 Q28068195-8D7BE63A-2F4D-4EAE-9DC4-5621B71E4A61 Q28082279-1C7E20FD-AD9F-4835-8BA4-E8D00C5CFFDA Q28241366-1A3F2508-4213-40E3-9F2B-AC165FAD0368 Q28383563-95433DE5-21BF-42F6-BFD9-660A4DA78D78 Q28654400-7D3C53E7-E51F-43DF-A6EC-678F4439795A Q28655239-3D889E96-A099-4E23-97E9-46F093A30A5F Q30100986-15D15D75-D542-4A6E-9402-4B3993EADA36 Q30814231-D5A4D550-992A-423C-BB31-9DFE2FBBB6E0 Q30847874-D5C49CCC-699F-4DFD-9CD2-F0DCC116230A Q30868628-8B24B5D5-271E-447E-980D-32E9B59D19EA Q30916063-43437E8A-339D-4DD7-92D9-4AC2D0034A85 Q30996799-F08227CF-8316-4AE8-B547-CE04F5113490 Q31041660-50998B3A-370B-4234-BEA1-8A9FD6CA9089 Q31096423-D234D429-36EA-48F3-8757-E8E86F495CB2 Q31158920-588D4159-8789-4BE1-8688-B30F1FA73994 Q31162702-0F178681-AC5D-4274-ACEC-E03B555ECB8A Q33556068-C17947F5-6A30-4249-8FB6-4C3B1955EAED Q33642389-74B46E6C-4A65-4815-B08B-7B6499DE2218

P2860

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

http://www.wikidata.org/entity/Q37259426

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Imaging of tau pathology in a ...... ts compared to normal controls

@en

Imaging of tau pathology in a ...... s compared to normal controls.

@nl

type

label

Imaging of tau pathology in a ...... ts compared to normal controls

@en

Imaging of tau pathology in a ...... s compared to normal controls.

@nl

prefLabel

Imaging of tau pathology in a ...... ts compared to normal controls

@en

Imaging of tau pathology in a ...... s compared to normal controls.

@nl

P1433

Q37259426-168AA57A-94A8-412E-8876-BFA2E3154F89

P1476

Q37259426-522A3D19-5EF7-4335-9DB8-79C1E4DD0196

P2093

Q37259426-0A3AD773-8BB3-45E7-93AE-C81873C8E0FD

Q37259426-0A58F067-AE37-42BB-B488-072E4AD9A6BC

Q37259426-1118165A-5B26-417F-8DE9-23734E572983

Q37259426-2B41E3CB-2C3E-46DE-BC32-6F14DB0E745B

Q37259426-2FD0DF2D-27C3-4E69-92FF-03C5CDB22DC2

Q37259426-2FDFDD55-DF69-446D-B4B0-1CCAA8C09069

Q37259426-3086722E-F156-4AEB-843F-A84E39CD5A53

Q37259426-4057D67D-B130-4659-AF66-D61692026BB4

Q37259426-59B539FD-A725-42D9-BFB6-8FE98C02FC43

Q37259426-8E78ED96-1CA5-40A5-A40B-4BA9370DF953

P2860

Q37259426-0B568BB1-1392-4FE9-A745-5712A15955DE

Q37259426-14D2F90B-2E9B-4A4D-9930-D5687392C029

Q37259426-1A531693-1B6F-406C-B68C-B8B95324695B

Q37259426-206F45E3-3D3D-41AC-8D56-D0F64ECA8FBA

Q37259426-34DA9EF3-29CA-4FF6-9F10-A08C7EA7EC7F

Q37259426-4BEDF03A-879C-47E6-A61D-AAA96690A2DE

Q37259426-500CD347-FF83-4A56-8AED-B6CFDC05E554

Q37259426-503ACA46-F1BA-4D88-97B2-FBA35BBD1379

Q37259426-5BC5EEBC-D82C-4264-8F27-07CD2E03B999

Q37259426-5DA06EC4-0673-433D-8662-E5108CC12FEB

P304

Q37259426-9E2A27CA-0F57-49DE-BA9A-B3601C293E83

P31

Q37259426-5A9EE227-16E6-43B6-AF96-568DCD2D9592

P356

Q37259426-FD7190DC-9B0C-4ECB-A0C9-E4E5A2D4749C

P407

Q37259426-F90483CC-7EB8-4FB2-8B6B-AFDD15BA26E9

P433

Q37259426-5755F6B6-7CCF-4467-B770-32AD3392753D

P478

Q37259426-CB9329CE-65D7-45A0-8BB7-E40BF3D00ACB

P50

Q37259426-D759164B-B127-4C19-A6D3-F36207200C3A

P577

Q37259426-6C152151-A9A3-442E-98C0-98700B37BD0C

P5875

Q37259426-094D7835-17DE-41CF-B510-A718FAA1028D

P698

Q37259426-5C495679-378F-47AC-A0D2-FEE0FB2E2568

P921

Q37259426-8857579F-9AFB-48A6-9E09-E6A8045ECFF3

Q37259426-E2FD0C1B-F63D-46A9-9AC0-2375EE03B37B

Q37259426-fa41b929-3637-4139-8860-d31e9aa31d1d

P932

Q37259426-596C8EB9-9AA2-4119-9D38-B728A1A0C6D7

P356

J.NEURON.2013.07.037

P1433

P1476

Imaging of tau pathology in a ...... ts compared to normal controls

@en

P2093

Akihiko Takashima

http://www.w3.org/2001/XMLSchema#string

Bin Ji

http://www.w3.org/2001/XMLSchema#string

Harumasa Takano

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ito

http://www.w3.org/2001/XMLSchema#string

Hitoshi Shimada

http://www.w3.org/2001/XMLSchema#string

Hitoshi Shinotoh

http://www.w3.org/2001/XMLSchema#string

Ichio Aoki

http://www.w3.org/2001/XMLSchema#string

Jada Lewis

http://www.w3.org/2001/XMLSchema#string

Jun Maeda

http://www.w3.org/2001/XMLSchema#string

Kazuto Masamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathological stageing of Alzheimer-related changes

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Tau suppression in a neurodegenerative mouse model improves memory function

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.

The binding of thioflavin-T to amyloid fibrils: localisation and implications.

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.

A highly selective and specific PET tracer for imaging of tau pathologies.

Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

P304

1094-1108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEURON.2013.07.037

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

John Q. Trojanowski

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256836188

http://www.w3.org/2001/XMLSchema#string

P698

24050400

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3809845

http://www.w3.org/2001/XMLSchema#string